Recombinant Sorangium cellulosum Queuine tRNA-ribosyltransferase (tgt) is a recombinant protein produced through heterologous expression in E. coli. It catalyzes the exchange of guanine in tRNA with queuine, a hypermodified nucleoside critical for translational fidelity in eukaryotes and certain bacteria .
The enzyme belongs to the glycosyltransferase family (EC 2.4.2.29) and exhibits ping-pong kinetics:
Substrate Binding: A covalent intermediate forms between a catalytic aspartate and tRNA ribose 34, releasing guanine .
Catalytic Efficiency:
The enzyme replaces guanine in tRNA with queuine through a two-step transglycosylation reaction :
Guanine Release: Ribose 34 of tRNA forms a covalent bond with the enzyme’s aspartate, displacing guanine .
Queuine Incorporation: PreQ₁ (a queuine precursor) binds and is transferred to the tRNA .
tRNA Modification Studies: Used to investigate queuosine biosynthesis and its role in translational accuracy .
Industrial Biotechnology: S. cellulosum genomes encode diverse lipolytic enzymes, suggesting potential for enzyme engineering .
Gut Microbiome Dynamics: Competes with host enzymes for queuine precursors, impacting human health .
Cusabio: Recombinant Sorangium cellulosum Queuine tRNA-ribosyltransferase (tgt) Datasheet .
Structural and functional insights into human tRNA guanine transglycosylase .
S-adenosylmethionine:tRNA ribosyltransferase-isomerase characterization .
Cusabio: Recombinant Sorangium cellulosum Queuine tRNA-ribosyltransferase (tgt) Datasheet (Alternative) .
KEGG: scl:sce1652
STRING: 448385.sce1652
Queuine tRNA-ribosyltransferase (EC 2.4.2.29) is an enzyme belonging to the glycosyltransferase family, specifically the pentosyltransferases. This enzyme catalyzes a critical base-exchange reaction in tRNA processing, where it exchanges a guanine (G) residue at the wobble position (position 34) of the anticodon with queuine in tRNAs with GU(N) anticodons . The chemical reaction can be represented as:
[tRNA]-guanine + queuine → [tRNA]-queuine + guanine
This reaction is fundamental to the formation of queuosine, a hypermodified nucleoside found in tRNAs specific for aspartic acid, asparagine, histidine, and tyrosine . The enzyme's activity is essential for proper tRNA function and, consequently, for the fidelity and efficiency of protein synthesis. In bacterial systems like Sorangium cellulosum, this enzyme contributes to the complex machinery regulating translation through tRNA modification.
Optimal storage and handling protocols for Recombinant Sorangium cellulosum Queuine tRNA-ribosyltransferase are essential for maintaining enzyme activity and ensuring experimental reproducibility. The following methodological guidelines should be observed:
Storage temperature: Store the protein at -20°C for regular use, or at -80°C for extended storage to prevent degradation .
Reconstitution procedure:
Briefly centrifuge the vial before opening to bring contents to the bottom
Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration between 5-50% (with 50% being optimal for most applications)
Aliquot the reconstituted protein for long-term storage at -20°C/-80°C
Freeze-thaw considerations: Repeated freezing and thawing should be avoided as it can compromise protein integrity and activity. Working aliquots can be stored at 4°C for up to one week .
Shelf life expectations: The liquid form typically has a shelf life of approximately 6 months when stored at -20°C/-80°C, while the lyophilized form can remain viable for up to 12 months under the same storage conditions .
These handling procedures are designed to preserve the structural integrity and enzymatic activity of the recombinant protein, thereby ensuring optimal performance in experimental applications.
Queuine tRNA-ribosyltransferase is identified and classified through several standardized systems in biochemistry and enzymology:
Enzyme Commission (EC) Classification:
EC Number: 2.4.2.29
Class 2: Transferases
Subclass 4: Glycosyltransferases
Alternative Nomenclature:
tRNA-guanine transglycosylase
Guanine insertion enzyme
tRNA transglycosylase
Q-insertase
Queuine transfer ribonucleate ribosyltransferase
Transfer ribonucleate glycosyltransferase
tRNA guanine transglycosidase
Systematic Name:
Database Identifiers:
Understanding this nomenclature is crucial for literature searches, database queries, and comparing findings across different research publications. The variety of names reflects the enzyme's discovery history and functional characterization by different research groups.
Queuine tRNA-ribosyltransferase operates through a sophisticated double-displacement mechanism that involves multiple steps and active site residues. The detailed catalytic process occurs as follows:
Initial binding phase: The enzyme recognizes and binds to specific tRNAs with GU(N) anticodons (tRNA-Asp, -Asn, -His, and -Tyr) .
Nucleophilic attack: A nucleophile in the enzyme's active site attacks the C1' position of nucleotide 34 (the wobble position) in the tRNA anticodon, resulting in the detachment of the guanine base from the RNA backbone .
Formation of covalent intermediate: This nucleophilic attack leads to the formation of a covalent enzyme-RNA intermediate, which stabilizes the reaction complex .
Substrate deprotonation: A proton acceptor in the active site deprotonates the incoming queuine (or its precursor PreQ1 in some systems), activating it for the subsequent reaction step .
Second nucleophilic attack: The deprotonated queuine performs a nucleophilic attack on the C1' of the ribose, displacing the enzyme and forming the product .
Post-incorporation modifications: In systems where PreQ1 is incorporated instead of queuine, additional enzymatic reactions convert PreQ1 to queuine (Q), ultimately resulting in the formation of the hypermodified nucleoside queuosine .
This elaborate mechanism ensures the precise exchange of nucleobases at a specific position in the tRNA, maintaining the fidelity of this critical modification. The crystal structures available in the PDB provide valuable insights into the spatial arrangement of the active site residues and their interactions with substrates during catalysis .
Q-glycosylation, the addition of sugar moieties to queuosine in tRNAs, has profound effects on translational processes and cellular proteostasis. Recent research has revealed several key mechanisms through which these modifications influence protein synthesis:
Translational speed regulation: Q-glycosylation slows down the elongation rate at cognate codons. Specifically, galactosylation affects the UAC codon, while mannosylation impacts the GAC (and GAU) codons . This controlled deceleration is thought to facilitate proper protein folding by providing additional time for nascent peptides to adopt correct conformations.
Suppression of stop codon readthrough: Galactosylation of queuosine has been demonstrated to suppress stop codon readthrough, enhancing the fidelity of translation termination . This function is critical for preventing the production of extended proteins with potentially deleterious effects.
Proteostasis maintenance: Cells lacking Q-glycosylation show increased accumulation of protein aggregates, indicating that these modifications play an essential role in maintaining proteostasis . The connection between translation rate and protein folding efficiency appears to be a key factor in this relationship.
Developmental impact: In vertebrate models, specifically zebrafish, knockout of the enzymes responsible for Q-glycosylation (qtgal and qtman) resulted in shortened body length, suggesting that these modifications are required for proper post-embryonic growth . This observation links tRNA modification to broader developmental processes.
The molecular basis for these effects has been elucidated through cryo-electron microscopy of human ribosome-tRNA complexes, which revealed how Q-glycosylations regulate codon recognition at the molecular level . These findings highlight the sophisticated role of tRNA modifications in fine-tuning the translation apparatus and maintaining cellular proteostasis.
Investigating the function of Queuine tRNA-ribosyltransferase in vitro requires specialized methodologies that target various aspects of the enzyme's activity and structural properties. The following experimental approaches are particularly valuable:
Enzymatic activity assays:
Base-exchange assays using radiolabeled substrates to track the incorporation of queuine into tRNA
Spectrophotometric methods monitoring guanine release
HPLC analysis of modified and unmodified tRNAs
Protein production and purification:
Structural analysis:
X-ray crystallography to determine three-dimensional structure
Cryo-electron microscopy to visualize enzyme-tRNA complexes
NMR spectroscopy for dynamics studies
Binding studies:
Isothermal titration calorimetry (ITC) to measure binding affinities
Surface plasmon resonance (SPR) for real-time binding kinetics
Fluorescence anisotropy to assess protein-RNA interactions
Reconstitution experiments:
For example, researchers have successfully employed biochemical approaches to identify RNA glycosylases (QTGAL and QTMAN) and reconstitute Q-glycosylation of tRNAs using nucleotide diphosphate sugars . These methodologies provide powerful tools for dissecting the enzyme's function, substrate specificity, and catalytic mechanism in controlled laboratory conditions.
Queuine tRNA-ribosyltransferase exhibits notable evolutionary conservation but also displays species-specific differences that reflect adaptations to different cellular environments. A comparative analysis reveals several key distinctions:
| Feature | Sorangium cellulosum | Human | E. coli |
|---|---|---|---|
| Protein Structure | 394 amino acids, single subunit | Two-subunit complex (QTRT-1 interacts with QTRTD1) | Single subunit TGT enzyme |
| Substrate Specificity | tRNA-guanine and queuine | tRNAs with GU(N) anticodons (tRNA-Asp, -Asn, -His, -Tyr) | Uses preQ1 rather than queuine as substrate |
| Catalytic Mechanism | Double-displacement | Double-displacement | Similar mechanism but with bacterial-specific features |
| Post-modification | Not established | Further glycosylation of Q to form galQ and manQ | No glycosylation pathway identified |
| Cellular Location | Cytoplasmic | Cytoplasmic | Cytoplasmic |
A particularly significant difference is that in human cells, queuine tRNA-ribosyltransferase functions as a heterodimer, with QTRT-1 interacting with QTRTD1 to form the active enzyme complex . This contrasts with the single-subunit enzyme found in Sorangium cellulosum . Additionally, while eukaryotic systems generally use queuine directly, bacterial systems typically incorporate preQ1, which is then converted to queuosine through additional enzymatic steps .
These comparative differences provide valuable insights into the evolution of this enzyme family and can inform experimental design when using recombinant enzymes from different species as research tools or therapeutic targets.
Knockout models have emerged as powerful tools for investigating the physiological relevance of Queuine tRNA-ribosyltransferase and related enzymes in vivo. Effective experimental strategies include:
Cell line knockout approaches:
CRISPR-Cas9 genome editing to create precise knockouts of tgt genes
Analysis of translational changes through ribosome profiling
Assessment of proteostasis through protein aggregation assays
Rescue experiments with wild-type or mutant versions of the enzyme
Animal model development:
Generation of zebrafish qtgal and qtman knockout lines to study developmental effects
Phenotypic characterization focused on growth parameters and morphology
Tissue-specific expression analysis of tgt and related genes
Molecular phenotyping through transcriptomics and proteomics
Phenotypic analysis methodologies:
Molecular consequence analysis:
Recent research utilizing knockout models has revealed significant physiological insights, such as the finding that zebrafish lacking Q-glycosylation enzymes display shortened body length, suggesting these modifications are required for proper post-embryonic growth in vertebrates . Additionally, ribosome profiling of knockout cells demonstrated that Q-glycosylation slows down elongation at specific codons, providing a mechanistic explanation for the observed phenotypes .
Recombinant Queuine tRNA-ribosyltransferase offers diverse applications in RNA modification research, spanning from fundamental mechanistic studies to therapeutic explorations:
Synthetic biology applications:
Engineering tRNAs with site-specific modifications to study translation dynamics
Creating artificial translation systems with controlled modification states
Developing biosensors for RNA modification states in complex samples
Structural biology approaches:
Co-crystallization with substrate analogs to elucidate binding mechanisms
Time-resolved structural studies to capture catalytic intermediates
Structure-guided design of inhibitors or activity modulators
Disease model investigations:
Exploring the relationship between tRNA modifications and neurodegenerative diseases
Investigating cancer-associated alterations in tRNA modification patterns
Studying the role of queuosine in microbial pathogenesis
Methodological innovations:
Translational regulation studies:
The successful reconstitution of Q-glycosylation using purified enzymes and nucleotide diphosphate sugars represents a significant methodological advancement in this field . Such systems enable detailed mechanistic studies of the enzymes involved and provide platforms for investigating the functional consequences of these modifications in controlled environments.